# Trade Mark Journal No.2026/002 9 January 2026

## WO0000001893351 (5)

Office of origin: United States of America

Date of International Registration:24 November 2025
Date of designation in the UK: 24 November 2025

International priority date claimed: 30 May 2025 (United States of America) (99211593)

Class 5
  Pharmaceutical preparations for the treatment of anaphylaxis; pharmaceutical preparations for the treatment of allergic reactions, namely, emergency treatment of type 1 allergic reactions; pharmaceutical preparations for the treatment of low blood pressure, intraocular pressure and broncho-constriction.

Hikma Pharmaceuticals USA Inc.

Representative: Deborah Liu Corpus Chrisman Gallo Tochtrop LLC, 629 Euclid Ave., Suite 1101, Cleveland OH 44114, UNITED STATES OF AMERICA